Life science organizations, like other healthcare participants, are being challenged to better define and demonstrate the benefits their products bring to stakeholders to meet value-based reimbursement models.
But the headwinds to greater transparency are strong. Research shows the ability to commercialize and market current and future products, including the pitfalls and opportunities of pre-clinical and clinical trials, ranks high among concerns. These concerns are being complicated by an ever changing and demanding regulatory environment, increased M & A activity, and steep competition.
With just one in ten new drugs making it to market, life sciences organizations need to innovate and get in front of health care professionals and patients to provide education, reduce prescription abandonment, offer financial support for patients, help track efficacy and side effects, and alert providers to clinical research options.
DrFirst has the depth and breadth of provider relationships and technology to help life sciences organizations embrace these challenges and achieve your business objectives.